Jabra Enhance Select 300 vs Lexie B3

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 among 65 OTC hearing aids tested, placing it in the top 25% of its category. In our testing, the Enhance Select 300 demonstrates notable strengths in speech clarity for quiet environments, scoring 0.85 points above the OTC category average. Feedback handling is excellent at 5.0/5, and own-voice comfort scores a solid 3.5/5—nearly a full point above average for the category. Music streaming performance, while above average for OTC devices, remains mixed in absolute terms at 2.6/5. The device's main limitation appears in challenging listening environments. Speech-in-noise performance scored 1.5/5, which is low in absolute terms and essentially matches the category average. Users who frequently encounter noisy restaurants, busy offices, or crowded gatherings may find this a meaningful constraint. The Enhance Select 300 is best suited for individuals who primarily need improved hearing in quieter settings such as home conversations, one-on-one meetings, or watching television. It offers reliable streaming to both iPhone and Android devices, rechargeable batteries, and hands-free functionality. Shoppers seeking stronger noise performance at this price point may want to compare alternatives like the Lucid Tala or Audicus Omni 2, which scored higher overall in our testing.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.